Roivant Sciences Stock Buy Hold or Sell Recommendation
| ROIV Stock | USD 12.53 0.71 6.01% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Roivant Sciences is 'Cautious Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Roivant Sciences given historical horizon and risk tolerance towards Roivant Sciences. When Macroaxis issues a 'buy' or 'sell' recommendation for Roivant Sciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Roivant Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide. Note, we conduct extensive research on individual companies such as Roivant and provide practical buy, sell, or hold advice based on investors' constraints. Roivant Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Roivant |
Execute Roivant Sciences Buy or Sell Advice
The Roivant recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Roivant Sciences. Macroaxis does not own or have any residual interests in Roivant Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Roivant Sciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Insignificant | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Roivant Sciences Trading Alerts and Improvement Suggestions
| Roivant Sciences currently holds about 1.94 B in cash with (765.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.76. | |
| Over 79.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Thompson Siegel Walmsley LLC Takes 5.93 Million Position in Roivant Sciences Ltd. - MarketBeat |
Roivant Sciences Returns Distribution Density
The distribution of Roivant Sciences' historical returns is an attempt to chart the uncertainty of Roivant Sciences' future price movements. The chart of the probability distribution of Roivant Sciences daily returns describes the distribution of returns around its average expected value. We use Roivant Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Roivant Sciences returns is essential to provide solid investment advice for Roivant Sciences.
| Mean Return | 0.12 | Value At Risk | -2.52 | Potential Upside | 2.87 | Standard Deviation | 1.73 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Roivant Sciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Roivant Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Roivant Sciences, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Roivant Sciences back and forth among themselves.
| Shares | Woodline Partners Lp | 2024-06-30 | 8 M | Geode Capital Management, Llc | 2024-09-30 | 7.7 M | Citadel Advisors Llc | 2024-09-30 | 5.9 M | Amvescap Plc. | 2024-06-30 | 5.9 M | Anchorage Advisors, Llc | 2024-09-30 | 4.8 M | Norges Bank | 2024-06-30 | 4.2 M | Goldman Sachs Group Inc | 2024-06-30 | 4.2 M | Pointstate Capital Lp | 2024-09-30 | 4.1 M | Toms Capital Investment Management Lp | 2024-09-30 | 4 M | Sb Investment Advisers (uk) Ltd | 2024-09-30 | 65.9 M | Qvt Financial Lp | 2024-09-30 | 65.8 M |
Roivant Sciences Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 1.3B | (127.6M) | (67.6M) | (381.9M) | 4.9B | 5.1B | |
| Free Cash Flow | (766.7M) | (557.9M) | (695.2M) | (856.1M) | (766.7M) | (805.0M) | |
| Other Non Cash Items | (264.3M) | 191.2M | (340.2M) | 33.4M | (5.2B) | (5.0B) | |
| Capital Expenditures | 4.9M | 5.8M | 17.4M | 12.7M | 1.4M | 1.3M | |
| Net Income | (519.4M) | (900.2M) | (924.1M) | (1.1B) | 4.2B | 4.4B | |
| End Period Cash Flow | 2.2B | 2.1B | 2.1B | 1.7B | 6.6B | 6.9B | |
| Change To Netincome | (2.0B) | 147.3M | 222.3M | 275.9M | 317.2M | 333.1M |
Roivant Sciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Roivant Sciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Roivant Sciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Roivant stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.01 | |
β | Beta against Dow Jones | 0.82 | |
σ | Overall volatility | 1.75 | |
Ir | Information ratio | -0.0055 |
Roivant Sciences Volatility Alert
Roivant Sciences has relatively low volatility with skewness of 0.35 and kurtosis of 1.25. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Roivant Sciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Roivant Sciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Roivant Sciences Fundamentals Vs Peers
Comparing Roivant Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Roivant Sciences' direct or indirect competition across all of the common fundamentals between Roivant Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Roivant Sciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Roivant Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Roivant Sciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Roivant Sciences to competition |
| Fundamentals | Roivant Sciences | Peer Average |
| Return On Equity | 1.29 | -0.31 |
| Return On Asset | -0.18 | -0.14 |
| Profit Margin | 37.25 % | (1.27) % |
| Operating Margin | (74.46) % | (5.51) % |
| Current Valuation | 3.79 B | 16.62 B |
| Shares Outstanding | 727.95 M | 571.82 M |
| Shares Owned By Insiders | 29.55 % | 10.09 % |
| Shares Owned By Institutions | 79.46 % | 39.21 % |
| Number Of Shares Shorted | 46.57 M | 4.71 M |
| Price To Book | 1.77 X | 9.51 X |
| Price To Sales | 70.64 X | 11.42 X |
| Revenue | 124.8 M | 9.43 B |
| Gross Profit | (477.06 M) | 27.38 B |
| EBITDA | 4.31 B | 3.9 B |
| Net Income | 4.23 B | 570.98 M |
| Cash And Equivalents | 1.94 B | 2.7 B |
| Cash Per Share | 2.76 X | 5.01 X |
| Total Debt | 499.75 M | 5.32 B |
| Debt To Equity | 0.28 % | 48.70 % |
| Current Ratio | 6.20 X | 2.16 X |
| Book Value Per Share | 7.03 X | 1.93 K |
| Cash Flow From Operations | (765.27 M) | 971.22 M |
| Short Ratio | 11.66 X | 4.00 X |
| Earnings Per Share | 5.54 X | 3.12 X |
| Target Price | 16.21 | |
| Number Of Employees | 908 | 18.84 K |
| Beta | 1.24 | -0.15 |
| Market Capitalization | 9.12 B | 19.03 B |
| Total Asset | 7.22 B | 29.47 B |
| Retained Earnings | 576.17 M | 9.33 B |
| Working Capital | 6.47 B | 1.48 B |
| Net Asset | 7.22 B |
Note: Disposition of 10945 shares by Venker Eric of Roivant Sciences at 11.49 subject to Rule 16b-3 [view details]
Roivant Sciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Roivant . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Roivant Sciences Buy or Sell Advice
When is the right time to buy or sell Roivant Sciences? Buying financial instruments such as Roivant Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Roivant Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Obamacare Repeal Thematic Idea Now
Obamacare Repeal
Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal. The Obamacare Repeal theme has 56 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Repeal Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Roivant Stock Analysis
When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.